Loading clinical trials...
Loading clinical trials...
Oxaliplatin, Irinotecan, and Capecitabine as a Combination Regimen for First-Line Treatment of Advanced or Metastatic Colorectal Cancer
Conditions
Interventions
Capecitabine
irinotecan hydrochloride
+1 more
Locations
4
Switzerland
Kantonsspital Graubuenden
Chur, Switzerland
Hopital Cantonal Universitaire de Geneve
Geneva, Switzerland
Hirslanden Klinik Aarau
Lausanne, Switzerland
City Hospital Triemli
Zurich, Switzerland
Start Date
May 1, 2005
Primary Completion Date
August 1, 2007
Completion Date
October 1, 2011
Last Updated
June 5, 2012
NCT04704661
NCT06696768
NCT05489211
NCT04657068
NCT06625775
NCT06445062
Lead Sponsor
Swiss Cancer Institute
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions